Marine Drugs (Jun 2020)

Astaxanthin Counteracts Excitotoxicity and Reduces the Ensuing Increases in Calcium Levels and Mitochondrial Reactive Oxygen Species Generation

  • Francisca García,
  • Pedro Lobos,
  • Alejandra Ponce,
  • Karla Cataldo,
  • Daniela Meza,
  • Patricio Farías,
  • Carolina Estay,
  • Felipe Oyarzun-Ampuero,
  • Rodrigo Herrera-Molina,
  • Andrea Paula-Lima,
  • Álvaro O. Ardiles,
  • Cecilia Hidalgo,
  • Tatiana Adasme,
  • Pablo Muñoz

DOI
https://doi.org/10.3390/md18060335
Journal volume & issue
Vol. 18, no. 6
p. 335

Abstract

Read online

Astaxanthin (ASX) is a carotenoid pigment with strong antioxidant properties. We have reported previously that ASX protects neurons from the noxious effects of amyloid-β peptide oligomers, which promote excessive mitochondrial reactive oxygen species (mROS) production and induce a sustained increase in cytoplasmic Ca2+ concentration. These properties make ASX a promising therapeutic agent against pathological conditions that entail oxidative and Ca2+ dysregulation. Here, we studied whether ASX protects neurons from N-methyl-D-aspartate (NMDA)-induced excitotoxicity, a noxious process which decreases cellular viability, alters gene expression and promotes excessive mROS production. Incubation of the neuronal cell line SH-SY5Y with NMDA decreased cellular viability and increased mitochondrial superoxide production; pre-incubation with ASX prevented these effects. Additionally, incubation of SH-SY5Y cells with ASX effectively reduced the basal mROS production and prevented hydrogen peroxide-induced cell death. In primary hippocampal neurons, transfected with a genetically encoded cytoplasmic Ca2+ sensor, ASX also prevented the increase in intracellular Ca2+ concentration induced by NMDA. We suggest that, by preventing the noxious mROS and Ca2+ increases that occur under excitotoxic conditions, ASX could be useful as a therapeutic agent in neurodegenerative pathologies that involve alterations in Ca2+ homeostasis and ROS generation.

Keywords